Last updated 2026-06-18
- Raised funding round, Feb 2018
Total raised
—
Last: 2018-02
Stage
Seed
Founded
2018
Headcount
2
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
BacoCure is developing a novel bacterial product for local therapy (intravesicular) of patients with non-muscle invasive bladder cancer. BacoCure's lead product is a novel mutated and inactivated uropathogenic bacteria that has demonstrated impressive anti-tumor effects via a novel and differentiated mechanism of action with a better safety profile compared to Bacillus Calmette-Guerin. The product is at an advanced preclinical development stage.
Funding history · 1 round · — total
2018-02
Undisclosed
Q&A
- What is BacoCure's primary focus?
- BacoCure is developing a novel bacterial product for the local therapy of patients with non-muscle invasive bladder cancer.
- What is the status of BacoCure?
- BacoCure is currently inactive and ceased to operate in January 2022.
- When was BacoCure founded?
- BacoCure was founded in February 2018.
- Who are the founders of BacoCure?
- The founders of BacoCure are Ofer Mandelboim, Yutkin Vladimir, and Gili (Gilad) Bachrach.
- What is the product stage of BacoCure's lead product?
- BacoCure's lead product is at an advanced preclinical development stage.
- Has BacoCure received any funding?
- BacoCure received funding in February 2018 from Integra Holdings.
Team · 3
Founder · Founder & Researcher
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProvidersPatients
Business model
B2B
Highlights
1 Patents
Tags
bacteriapharmaceuticalsnon-invasivecanceroncologypatients
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2018-2 |
|---|---|
| Employees (exact) | 2 |
| Status reason | Non Active, Jan 2022 ceased to operate |